IRCT20250222064811N1 IRCT 2025-03-09 Khyber Medical University Comparing Walking Exercises to Improve Blood Sugar Control in Type 2 Diabetes Patients. Comparison of the Immediate Effect of Flat Treadmill Walking with Soleus Pushups versus Inclined Treadmill Walking on Glucose Levels in Type 2 Diabetes Patients: A Randomized Controlled Trial. 2025-04-01 anticipated 48 Complete https://irct.ir/trial/82057 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Method of Randomization: Simple randomization using a lottery method. Unit of Randomization: Individual participants. Randomization Strata: No stratification is used in this study. Tools Used in Randomization: A lottery draw is used to generate the random sequence. How the Random Sequence Was Built: The random sequence is generated through a lottery draw, where participants randomly select their group assignment. Allocation Concealment: Allocation concealment is not explicitly implemented, as participants are aware of their group assignment immediately after the lottery draw. However, the lottery method ensures that the sequence is unpredictable until the participant makes their selection. N/A Type 2 diabetes. Intervention 1: Intervention group: Flat treadmill walking with soleus pushups. Intervention 2: Intervention group: inclined treadmill walk. Yes - There is a plan to make this available What will be shared: COMPARISON OF THE IMMEDIATE EFFECT OF FLAT TREADMILL WALKING WITH SOLEUS PUSHUPS VERSUS INCLINED TREADMILL WALKING ON GLUCOSE LEVELS IN TYPE 2 DIABETES PATIENTS: A RANDOMIZED CONTROLLED TRIAL. Additional Details: This dataset includes deidentified participant data collected during the study, specifically focusing on blood glucose levels before and after exercise interventions. The shared data will include demographic information, exercise type (flat treadmill walking with soleus pushups or inclined treadmill walking), and corresponding glucose measurements. When: After data collection and analysis it will be provided which will probably take 6 months. To whom: Deidentified individual participant data (IPD) and supporting documents will be available to researchers from academic institutions, research organizations, and other entities upon request. Access will be granted for the purpose of scientific research and analysis, subject to approval by the study's principal investigator and adherence to ethical guidelines. The data will be shared through a secure platform, ensuring confidentiality and compliance with data protection regulations. Conditions: Deidentified IPD will be shared for scientific research related to the study's objectives. Requests must be made in writing, specifying intended use. The principal investigator will review requests based on scientific merit, relevance, and adherence to ethical guidelines. Where to obtain: Applicants can obtain the data/documents by contacting the principal investigator, Rabia Qubais, via email at rqubais4@gmail.com. Requests should include a brief description of the intended use of the data. How to obtain: Initial Contact: Applicants should contact the principal investigator, Rabia Qubais, via email at rqubais4@gmail.com to express interest in accessing the data/documents. Application Submission: A formal request must be submitted, including a detailed description of the intended use of the data and how it aligns with the study's objectives. Review Process: The request will be reviewed by the principal investigator and relevant stakeholders to ensure alignment with ethical guidelines and study objectives. Approval: Once approved, the applicant will receive instructions on how to access the data/documents securely. Timeline: The review process typically takes 2-4 weeks, depending on the complexity of the request and the availability of the review committee. Communication: Applicants will be notified via email regarding the status of their request. If additional information is required, they will be contacted promptly. Comments: No additional comments at this time. For any further inquiries or clarification regarding the study or data sharing, please contact the principal investigator via the provided contact information.